Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00141791 · ClinicalTrials.gov registry record · Phase 2

Study Evaluating Etanercept in Moderate to Severe Asthma

A Phase 2 study of Asthma, sponsored by Wyeth is now a wholly owned subsidiary of Pfizer.

Completed
Registry status
Phase 2
Development phase
120
Enrollment target
13
Study locations

NCT00141791 is a Phase 2 study of Asthma that has completed, run by Wyeth is now a wholly owned subsidiary of Pfizer. The registered enrollment target is 120 participants, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (92% lower). The trial reports 13 study locations across 11 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00141791, a Phase 2 study of Asthma, has completed, sponsored by Wyeth is now a wholly owned subsidiary of Pfizer.

COMPLETED
Registry status
Phase 2
Development phase
120 participants
Enrollment target
13
Study locations

Study Summary

The primary objective of the study is to assess the efficacy and safety of etanercept 25 mg given twice weekly in subjects with moderate to severe persistent asthma.

Conditions Studied

Asthma

Interventions

  • DRUG Etanercept

Study Locations (13)

Florida

  • - Sarasota
  • - Tallahassee
  • - Valrico

Alabama

  • - Birmingham

Colorado

  • - Denver

Louisiana

  • - Covington

Maryland

  • - Wheaton

Massachusetts

  • - Boston

New York

  • - Rockville Centre

North Carolina

  • - Winston-Salem

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2005-05
Est. Completion 2006-07
Phase Phase 2

Sponsor

Wyeth is now a wholly owned subsidiary of Pfizer

167 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00141791

The ClinicalTrials.gov registry entry for NCT00141791 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (92% lower). The listed sponsor is Wyeth is now a wholly owned subsidiary of Pfizer, which has 167 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Asthma appearing as the primary indexed condition, and to 1 intervention - of which Etanercept is the first listed.

NCT00141791 reports 13 study locations spanning 11 distinct geographic areas - top geographies include Florida, Alabama, Colorado.

Frequently Asked Questions

What is clinical trial NCT00141791 about?

NCT00141791 is a clinical study titled "Study Evaluating Etanercept in Moderate to Severe Asthma". The primary objective of the study is to assess the efficacy and safety of etanercept 25 mg given twice weekly in subjects with moderate to severe persistent asthma.

What is the current status of trial NCT00141791?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 120 participants. The study started on 2005-05. Estimated completion is 2006-07.

What conditions does trial NCT00141791 study?

This clinical trial studies the following conditions: Asthma.

What interventions are being tested in trial NCT00141791?

The interventions under investigation include: Etanercept (DRUG).

Who is sponsoring clinical trial NCT00141791?

This trial is sponsored by Wyeth is now a wholly owned subsidiary of Pfizer, which has 167 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00141791 being conducted?

This trial has 13 study locations across Alabama, Colorado, Florida, Louisiana, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Asthma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Asthma

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.